Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia

Transcriptional regulation of Annexin A2 promotes starvation-induced autophagy

(2015) Kevin Moreau et al.   Nature Communications

Annexin A2 Heterotetramer: Structure and Function

(2013) Alamelu Bharadwaj et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

N-terminal acetylation of annexin A2 is required for S100A10 binding

(2012) Ali Reza Nazmi et al.   BIOLOGICAL CHEMISTRY

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

(2012) H. J. Iland et al.   BLOOD

The Annexin A2/S100A10 System in Health and Disease: Emerging Paradigms

(2012) Nadia Hedhli et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice

(2011) B. Huang et al.   BLOOD

The role of the annexin A2 heterotetramer in vascular fibrinolysis

(2011) P. A. Madureira et al.   BLOOD

Regulation of fibrinolysis by S100A10 in vivo

(2011) A. P. Surette et al.   BLOOD

Regulation of S100A10 by the PML-RAR-  oncoprotein

(2011) P. A. O'Connell et al.   BLOOD

Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

(2011) J. H. Park et al.   BLOOD

The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia

(2011) Karen A. Breen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

(2011) H. Iland et al.   HAEMATOLOGICA

The annexin A2 system and vascular homeostasis

(2011) Elle C. Flood et al.   VASCULAR PHARMACOLOGY

Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data

(2010) Vikram Mathews et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term survey of outcome in acute promyelocytic leukemia: a single center experience in 340 patients

(2010) Yue-Jun Liu et al.   MEDICAL ONCOLOGY

PML/RARα fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association

(2010) Jinsong Yan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant or an Arsenic Trioxide–Based Regimen

(2009) Rajasekar Thirugnanam et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia

(2009) J. Zhou et al.   BLOOD

Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

(2009) J. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Annexin A2 Regulates the Levels of Plasmin, S100A10 and Fascin in L5178Y Cells

(2008) Yingchun Hou et al.   CANCER INVESTIGATION

Endothelial Cell Annexin A2 Regulates Polyubiquitination and Degradation of Its Binding Partner S100A10/p11

(2008) Kai-Li He et al.   JOURNAL OF BIOLOGICAL CHEMISTRY